EMAIL DETAILS

To view this email as a web page, click the link below:
http://info.akingump.com/rs/vm.ashx?ct=24F76D18D5E10AEDC1D180ADDA2E941DDDBE7BB3D38714DD4CF371647BF8D90DDD78035

you're invited!!
Free Webinar!

Tuesday, September 27, 2011

2:00 PM EDT / 11:00 AM PDT

Webinar - 60 Minutes

Register here
http://info.akingump.com/rs/ct.aspx?ct=24F76D18D5E10AEDC1D180ADDA2E941DDDBE7B85EBB82EEC69D3565A51D4F524EE490FDA90851D8B3641762BB75D5AF089E6830F4B16104EFD995D5D93A925818664A0E31507E0B518587C602BDF73A11F83264C816ED3301354F274836C008B5998B8B5F1AB571AB6E82EAAB36

Akin Gump Strauss Hauer & Feld LLP & Thomson Reuters invite you to attend -

What You Don't Know About Regulatory Activity Can Hurt You: the Park Doctrine, the Hill and Criminal Prosecution of Executives and In-House Counsel

Akin Gump lawyers Mark Mansour, Stephen Mansfield and John Sopko will present a panel discussion addressing the Park Doctrine. Topics of discussion will include--

- factors the FDA has identified as guiding its decision whether to refer an executive for prosecution

- regulatory effects on drug, device and food companies

- defense strategies for avoiding prosecution and defending against any such charges

- congressional implications


Speakers

Mark Mansour
http://info.akingump.com/rs/ct.aspx?ct=24F76D18D5E10AEDC1D180ADDA2E941DDDBE448DEDBF2EF76EC05E6
has practiced U.S. and international food and drug law since 1991. He works with clients in the food, pharmaceutical, medical device, dietary supplement and cosmetic industries to secure regulatory approvals, maintain compliance and address public policy issues in the United States and in key global markets.

Stephen A. Mansfield
http://info.akingump.com/rs/ct.aspx?ct=24F76D18D5E10AEDC1D180ADDA2E941DDDBE5A8DEDBF2EFE72D74E57429
is an accomplished trial lawyer who has defended and prosecuted complex criminal actions for over 20 years. Mr. Mansfield conducts corporate investigations and defends corporations, officers, directors and employees against Securities and Exchange Commission (SEC) and Department of Justice (DOJ) investigations involving allegations of health care fraud, securities fraud, Foreign Corrupt Practices Act (FCPA) violations, technology and trade secret theft, payola, tax fraud, antitrust violations, environmental crimes, money laundering, customs fraud, political corruption and unfair and deceptive trade practices.
John F. Sopko
http://info.akingump.com/rs/ct.aspx?ct=24F76D18D5E10AEDC1D180ADDA2E941DDDBE4393E3A136F7676
focuses his practice on congressional and federal investigations. For over 30 years he has been involved in oversight and investigations either as a prosecutor, congressional counsel or senior adviser to the federal government.
If you have any questions, please contact:

Brian O'Shea
415-765-9512
boshea@akingump.com
mailto:boshea@akingump.com


© 2011 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. IRS Circular 230 Notice Requirement: This communication is not given in the form of a covered opinion, within the meaning of Circular 230 issued by the United States Secretary of the Treasury. Thus, we are required to inform you that you cannot rely upon any tax advice contained in this communication for the purpose of avoiding United States federal tax penalties. In addition, any tax advice contained in this communication may not be used to promote, market or recommend a transaction to another party.


If you would like to update your information or opt out from our mailing list, please click here
http://info.akingump.com/rs/ct.aspx?ct=24F76D18D5E10AEDC1D180ADDA2E941DDDBE6694E4B42FE473C656430495A625F45B10CEDEC11D8B375B353AF2575BFAD3F996404B0D140EE1D36E6DA0A524BFC851968A111AC0EB1A4B376F2CE628F93AB30A758F5EB143652B9766937D1DF227E8CC8BC69D2D450